The U.K.'s National Institute for Health and Clinical Excellence (NICE) has changed its policy on the Alzheimer's drugs Aricept, Exelon and Reminyl. Previously the drugs could only be prescribed to people with moderate to severe symptoms but they
Read More...
Read the complete post at http://mentalhealthupdate.blogspot.com/2011/03/nice-issues-new-alzheimers-guidelines.html
Posted
Mar 23 2011, 03:17 AM
by
Mental Health Update